Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLoewenstein Hospital
About this trial
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Up to 3 months following traumatic or non-traumatic SCL
Ability to give informed consent and cooperate
Disqualifiers
Pregnancy
Neurological or other medical conditions that may interfere with sensation
Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing)
Being treated with Pregabalin
Trial design
Design model
Parallel
Treatments tested in this trial
Pregabalin 75mg
DrugPregabalin 75 mg twice a day
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: PregabalinExperimental treatment 1 intervention
Group B: No treatmentNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Central pain
development of central pain by interview (yes /no )
Time frame
1 year2
McGill Pain Questionnaire
Range 0 -78. higher scores mean worse outcome.
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov